Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 60 % of short-term debt in 2024; threshold 65 %.
-
Annual account missing NBB
Fiscal year 2025 was expected before 30 April 2026 and has not been filed.
-
Busy address KBO
20 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2024
KOUTERLOS from Gent, company number BE0450036349, closed financial year 2024 with a result of € 18,619 after tax. For that financial year KOUTERLOS recorded a gross margin of € 55,337 and equity of € 321,265. Compared with financial year 2023, the result moved from € 17,873 to € 18,619. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 17, 2025.
€ 321,265
▲ 6% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 18,619
▲ 4% vs 2023
Profit after tax over the fiscal year.
€ 53,652
▲ 1% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 151,235.
Debts at end 2024
€ 352,144
▼ 9% vs 2023
€ 34,166 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.
€ 881
▼ 8% vs 2023
Supplier invoices still open on the last day of the fiscal year.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 42,230 | € 62,277 | € 58,543 | € 55,337 | ▼ 5% |
| Profit after taxes | € 5,918 | € 20,812 | € 17,873 | € 18,619 | ▲ 4% |
| Equity | € 263,961 | € 284,774 | € 302,647 | € 321,265 | ▲ 6% |
| Total debts | € 603,960 | € 517,006 | € 478,441 | € 444,765 | ▼ 7% |
| Cash | € 51,879 | € 53,435 | € 53,219 | € 53,652 | ▲ 1% |
| Land & buildings | € 762,490 | € 746,740 | € 726,456 | € 706,171 | ▼ 3% |
| Retained profit | € 93,931 | € 114,744 | € 132,616 | € 151,235 | ▲ 14% |
| Bank debt | € 448,097 | € 417,151 | € 385,177 | € 352,144 | ▼ 9% |
| Balance sheet total | € 867,921 | € 801,780 | € 781,088 | € 766,030 | ▼ 2% |
Key figures of KOUTERLOS, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 30 April 2026.
What happened to KOUTERLOS?
What happened at KOUTERLOS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Anton Stevens stepped down as director. NBB
- Gregory Mestdagh stepped down as director. NBB
- Jean-Pierre Van Overbergh stepped down as director. NBB
- Alex Ryndziewicz stepped down as director. NBB
- New annual accounts for financial year 2024: profit of € 18,619 (▲ 4% vs 2023). Source: NBB ↗
- Gregory Mestdagh became a director. NBB
- Anton Stevens became a director. NBB
- Jean-Pierre Van Overbergh became a director. NBB
In short
From € 5,918 profit in 2021 to € 18,619 profit in 2024.
Paid € 23,413 in corporate taxes since 2021.
Best year ever: 2022, with € 20,812 profit.
Management
The stake of FIDERO INVEST, Herwebo comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
KOUTERLOSThe shares are held by FIDERO INVEST (15%) and Herwebo (15%).
Directors
According to the 2024 annual accounts
since 2023 · until 2029
since 2024 · until 2029
Jean-Pierre Van Overbergh
Director
since 2023 · until 2029
Alex Ryndziewicz
Director
since 2023 · until 2029
Shareholders
15%
15%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 1091 box A
9051 Gent
Kouterlosstraat 125
9800 Deinze
Active since 3 August 1993
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
All companies at this address →Ceres Pharmaceuticals
€ 14.6 million revenue · 2025
What's Cooking Group
b+pharma Belgium
€ 287,023 gross margin · 2025
DGPharma
€ 94,120 gross margin · 2024
Ceres Pharma
€ 35.3 million revenue · 2025
+15 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0450.036.349
- VAT number
- BE 0450.036.349
- Registered office
- Kortrijksesteenweg 1091 bus A, 9051 Gent
- Names & denominations
- KOUTERLOS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 April 1993
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Exploitatie van sportaccommodaties
Sport- en recreatieonderwijs
Activiteiten van overige sportclubs
Verhuur en lease van sport- en recreatieartikelen